Julie Vassart
Rue De Bruxelles, 61
Namur, WAL 5000, Belgium
Namur, WAL 5000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Thrombin generation and the pharmacodynamics of oral anticoagulants.
Journal: Pharmacology & therapeutics
Published: June 11, 2026
Corrigendum to 'Impact of asundexian on a panel of coagulation assays'[Research and Practice in Thrombosis and Haemostasis 9(5) (2025) 102950].
Journal: Research and practice in thrombosis and haemostasis
Published: January 07, 2026
Impact of asundexian on a panel of coagulation assays.
Journal: Research and practice in thrombosis and haemostasis
Published: May 27, 2025
Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: March 14, 2025
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Journal: Thrombosis and haemostasis
Published: August 01, 2024
Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?" [Thromb. Res. 236 (2024) 236-239 TR_8963].
Journal: Thrombosis research
Published: June 19, 2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Journal: Thrombosis and haemostasis
Published: February 05, 2024
The DOAC (direct oral anticoagulant) Dipstick reliably excludes residual FXa inhibitors levels in the preoperative setting.
Journal: Thrombosis research
Published: January 30, 2024
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?
Journal: Thrombosis research
Published: January 08, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026